Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

66.50DKK
24 May 2013
Price Change (% chg)

kr.-0.50 (-0.75%)
Prev Close
kr.67.00
Open
kr.66.50
Day's High
kr.67.50
Day's Low
kr.66.50
Volume
30,382
Avg. Vol
139,506
52-wk High
kr.78.00
52-wk Low
kr.44.10

BAVA.CO

Chart for BAVA.CO

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines within biodefence, cancer and infectious diseases therapeutic areas. The Company operates within two segments: Cancer Vaccines and Infectious Disease. The Cancer Vaccines’ pipeline is focused on... (more)

Overall

Beta: 1.68
Market Cap (Mil.): kr.1,748.32
Shares Outstanding (Mil.): 26.09
Dividend: --
Yield (%): --

Financials

  BAVA.CO Industry Sector
P/E (TTM): -- 27.85 34.30
EPS (TTM): -9.20 -- --
ROI: -20.28 7.01 18.43
ROE: -21.75 11.53 19.30
Search Stocks

BRIEF-Bavarian Nordic to shift vaccine work to Denmark from Germany

Jan 11 - Bavarian Nordic A/S says: * consolidates its vaccine manufacturing in Denmark * to prepare its Kvistgaard facility for the future commercial production of its prostate cancer vaccine, Prostvac, and transfer its production of clinical trial material to the facility. * to close its operations in Berlin, Germany where it has been producing clinical trial material for its MVA-BN based vaccine candidates * planned changes do not affect company expectations for 2012 full year re

11 Jan 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
$250.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks